Please find enclosed copies of certificates from Kfin Technologies Limited under Regulation 74(5) of SEBI (Depositories And Participants) Regulations, 2018 for the quarter ended 31-March-2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries Ltd has submitted to BSE the certificates received from its Registrar & Share Transfer Agent, KFin Technologies Limited, under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31 March 2025. Separate certificates were issued by KFin to both CDSL and NSDL (both dated 2 April 2025) confirming that details of securities dematerialised and rematerialised during the quarter have been furnished to the stock exchanges. The filing was signed by Sachin Mehta, Joint Managing Director and Chief Financial Officer of the company on 21 April 2025.
This is a routine quarterly compliance filing with no business or financial impact. Shareholders and investors can take no action based on this filing as it only confirms that standard demat-related reporting obligations have been met.